
OLIN CORP
OLNNYSE🏆 #1836 by market capEarnings Oct 26US Equity
$18.62▼ $0.45 (−2.41%)
Live1h▼ 0.3%
24h▼ 2.4%
7d▼ 0.3%
14d▼ 16.0%
30d▼ 12.0%
1y▼ 5.7%
🏦Market Cap
$2.12B
Small Cap
📈Revenue Growth (YoY)
+2.6%
Slowing
📊Gross Margin
6.8%
Thin
💵FCF Margin
6.5%
Moderate
⚖️P/S Ratio
0.3x
Cheap
Otter Score
46
Weak
📊
Analyst Ratings
Price
$18.62
Total
35
Raised
6
Lowered
5
Avg PT
$24.13
H / L
$31 / $20
| Institution | Action | Rating | Date |
|---|---|---|---|
Mizuho | Reiterated | Neutral | 2026-07-31 |
Truist Securities | Reiterated | Hold | 2026-07-20 |
Goldman Sachs | Reiterated | Neutral | 2026-07-16 |
BMO Capital | Reiterated | Market Perform | 2026-07-06 |
B of A Securities | Downgraded | Buy → Underperform | 2026-06-30 |
JP Morgan | Reiterated | Neutral | 2026-06-18 |
UBS | Reiterated | Neutral | 2026-05-13 |
Morgan Stanley | Reiterated | Underweight | 2026-05-11 |
Citigroup | Reiterated | Neutral | 2026-04-16 |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-04-06 |
RBC Capital | Reiterated | Sector Perform | 2026-02-02 |
Keybanc | Reiterated | Overweight | 2026-02-02 |
Barclays | Reiterated | Equal Weight | 2025-05-28 |
Piper Sandler | Reiterated | Neutral | 2025-04-07 |
Deutsche Bank | Reiterated | Hold | 2024-07-29 |
Stifel | Reiterated | Buy | 2024-04-29 |
Fermium Research | Reiterated | Hold | 2023-10-30 |
Vertical Research | Downgraded | Buy → Hold | 2023-09-05 |
Credit Suisse | Reiterated | Underperform | 2023-07-28 |
Tudor Pickering | Upgraded | Hold → Buy | 2021-03-18 |
KeyBanc | Reiterated | Overweight | 2021-03-17 |
SunTrust Robinson Humphrey | Reiterated | Hold | 2020-03-26 |
Bank of America | Reiterated | Buy | 2019-11-04 |
Citi | Downgraded | Buy → Neutral | 2019-10-09 |
Nomura | Upgraded | Reduce → Neutral | 2019-04-15 |
Stifel Nicolaus | Reiterated | Buy | 2018-12-11 |
Standpoint Research | Reiterated | Buy | 2018-08-28 |
Susquehanna | Reiterated | Positive | 2018-08-02 |
Monness, Crespi, Hardt | Downgraded | Buy → Neutral | 2017-02-02 |
Longbow Research | Upgraded | Underperform → Neutral | 2017-02-02 |
Monness Crespi Hardt | Downgraded | Buy → Neutral | 2017-02-02 |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2016-06-28 |
Macquarie | Reiterated | Neutral | 2016-02-04 |
Sidoti & Co. | Upgraded | Neutral → Outperform | 2015-05-04 |
Dahlman Rose | Reiterated | Hold | 2013-01-10 |
One row per institution, most recent rating